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Leukemia-associated RhoGEF (LARG) is a novel 
RhoGEF in cytokinesis and required for the 
proper completion of abscission
Matthew K. Martza, Elda Grabockaa,*, Neil Beeharryb, Timothy J. Yenb, and Philip B. Wedegaertnera
aDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA 19107; bFox Chase 
Cancer Center, Philadelphia, PA 19111
ABSTRACT Proper completion of mitosis requires the concerted effort of multiple RhoGEFs. 
Here we show that leukemia-associated RhoGEF (LARG), a RhoA-specific RGS-RhoGEF, is re-
quired for abscission, the final stage of cytokinesis, in which the intercellular membrane is 
cleaved between daughter cells. LARG colocalizes with α-tubulin at the spindle poles before 
localizing to the central spindle. During cytokinesis, LARG is condensed in the midbody, 
where it colocalizes with RhoA. HeLa cells depleted of LARG display apoptosis during cytoki-
nesis with unresolved intercellular bridges, and rescue experiments show that expression of 
small interfering RNA–resistant LARG prevents this apoptosis. Moreover, live cell imaging of 
LARG-depleted cells reveals greatly delayed fission kinetics in abscission in which a popula-
tion of cells with persistent bridges undergoes apoptosis; however, the delayed fission kinet-
ics is rescued by Aurora-B inhibition. The formation of a Flemming body and thinning of mi-
crotubules in the intercellular bridge of cells depleted of LARG is consistent with a defect in 
late cytokinesis, just before the abscission event. In contrast to studies of other RhoGEFs, 
particularly Ect2 and GEF-H1, LARG depletion does not result in cytokinetic furrow regres-
sion nor does it affect internal mitotic timing. These results show that LARG is a novel and 
temporally distinct RhoGEF required for completion of abscission.
INTRODUCTION
Cytokinesis is the final stage of cellular division in which the cell is 
physically separated into two daughter cells. The mechanical act of 
partitioning the cytoplasm of the cell through ingression of the con-
tractile ring to draw together membrane must be tightly coordi-
nated with the segregation of genetic material. Failure to properly 
separate into daughter cells, or a miscue in timing between the 
completion of chromosomal segregation and doing so, can lead to 
tetraploidization of the cell, a phenomenon of genetic instability 
that has been shown to be beneficial to tumor formation (Fujiwara, 
2005). A critical component of this spatiotemporal control involves 
the small GTPase RhoA, whose localization and activation are main-
tained by Rho guanine nucleotide exchange factors (RhoGEFs) and 
GTPase-activating proteins (RhoGAPs). It is through the regulation 
in the interplay between RhoGEFs and RhoGAPs that RhoA translo-
cates to the equatorial cortex and initiates assembly and ingression 
of the contractile ring (Mishima et al., 2002; Bement et al., 2005; 
Yüce et al., 2005; Su et al., 2011a; Loria et al., 2012).
A concert of RhoGEFs act during mitosis to ensure proper as-
sembly and ingression of the cytokinetic furrow. MyoGEF has been 
shown to interact with the centrosome/spindle pole-associated pro-
tein (CSPP) and is necessary for recruitment of ECT2, RhoA, and 
nonmuscle myosin II to the central spindle (Asiedu et al., 2009). 
ECT2 is recruited to the central spindle and equatorial cortex and is 
necessary for cortical localization and activation of RhoA, a critical 
step in the establishment of the cleavage furrow at the equatorial 
cortex (Tatsumoto et al., 1999; Yüce et al., 2005; Nishimura and 
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ingression before condensing in the midbody during cytokinesis 
(Nishimura and Yonemura, 2006; Yonemura et al., 2004). Of interest, 
it is not until after full contractile ring ingression that LARG is ob-
served to colocalize with RhoA (Figure 1B). Taken together, these 
2011b). GEF-H1 was also shown to be important in directing the 
activation of RhoA during cleavage furrow ingression and may pro-
vide essential communication between the microtubule network 
responsible for segregating genomic material and the actomyosin-
driven furrow ingression process (Krendel et al., 2002; Birkenfeld 
et al., 2007; Chang et al., 2008; Fujishiro et al., 2008). Of interest, 
studies have yet to uncover a role for a RhoGEF in the regulation of 
abscission, the fission of daughter cells after the completion of fur-
row ingression. Nonetheless, RhoGEFs have been shown to be lo-
calized in the dense midbody structure within the intercellular bridge 
formed from cytokinetic furrow ingression, suggesting a possible 
role post furrow ingression for RhoGEFs.
Leukemia-associated RhoGEF (LARG), also known as ARHGEF12, 
is a RhoA-specific RhoGEF first identified as a fusion product with 
MLL in acute myeloid leukemia; it remains one of the few RhoGEFs 
to be found mutated in human cancers (Fukuhara et al., 2000). LARG 
is among a family of RhoGEFs activated by the Gα12/13 G protein 
subunits and is also responsible for RhoA activation in signaling 
through a diversity of receptors, such as plexin-B1 (Aurandt et al., 
2002; Perrot et al., 2002; Swiercz et al., 2002), insulin-like growth 
factor-1 (Becknell et al., 2003; Suzuki et al., 2007), histamine-H1 
(Pfreimer et al., 2012), and sphingosine 1-phosphate receptor 
(Medlin et al., 2010). Accordingly, LARG has been shown to be in-
volved in cell polarization, cell morphology, and invasion (Swiercz 
et al., 2002; Dubash et al., 2007; Kitzing et al., 2007; Goulimari et al., 
2008; Evelyn et al., 2009; Shi et al., 2009), including a report show-
ing that LARG, along with GEF-H1, is critical in regulation of the 
mechanical response to force generated on integrins (Guilluy et al., 
2011).
Given the role of LARG in a multitude of mechanical transduc-
tion pathways, we sought to determine whether LARG is a member 
of the growing assemblage of RhoGEFs critical for proper mitotic 
regulation and dynamics. Here we show that LARG is indeed a 
novel mitotic RhoGEF displaying a distinct localization pattern with 
prominent midbody localization upon furrow ingression and during 
abscission. Depletion of LARG results in a late cytokinetic defect, 
and together these data show that LARG has a distinct functional 
significance from previously determined mitotic RhoGEFs during 
abscission.
RESULTS
Immunofluorescence staining of LARG in HeLa cells revealed a dy-
namic localization pattern through the cell cycle (Figure 1A). In inter-
phase, LARG is predominantly found distributed evenly throughout 
the cytoplasm with a concentration colocalizing with α-tubulin at the 
microtubule-organizing center (MTOC), similar to localization pat-
terns previously identified for LARG (Goulimari et al., 2008). On ini-
tiation of mitosis and through early anaphase, LARG colocalizes with 
α-tubulin at the spindle poles and along microtubule tracks, as well 
as at the centrosomes. During late anaphase, before initiation of 
contractile ring ingression, LARG localizes to the spindle midzone. 
We did not find LARG localized at the cortex of the contractile ring, 
where ECT2 is known to concentrate just before initiation of ingres-
sion (Yüce et al., 2005). Finally, during telophase and cytokinesis, 
LARG is prominently localized within the intercellular bridge at the 
midbody, or Flemming body, the dense structure formed from the 
collapse of the spindle midzone. Strong midbody localization of 
LARG was also observed in noncancerous, immortalized RPE-1 cells 
(Supplemental Figure S1A), detected by multiple antibodies in HeLa 
cells (Supplemental Figure S1B), and lost on small interfering RNA 
(siRNA) depletion of LARG in HeLa cells (Supplemental Figure S1, C 
and D). RhoA concentrates at the cell cortex before contractile ring 
FIGURE 1: Mitotic distribution of LARG. (A, B) HeLa cells were fixed, 
and α-tubulin (red), RhoA (red), LARG (green; SC H70), and DNA 
(blue) were visualized by immunofluorescence microscopy, as 
described in Materials and Methods. Bar, 11 μm.
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increased apoptosis in LARG si cells was alleviated by introduction 
of an siRNA-resistant, mCherry-tagged LARG (Figure 2, D and E). 
Thus, on the basis of these observations of increased apoptosis 
and apoptotic cells connected by intercellular bridges after LARG 
depletion, we postulated that LARG was required for both cell via-
bility and mitotic progression.
To better understand where in mitosis LARG was functionally re-
quired, we monitored division by live cell microscopy of HeLa cells 
stably expressing green fluorescent protein (GFP)–H2B (Kanda et al., 
1998; Figure 3 and Supplemental Videos S1 and S2). LARG si cells 
proceed through early mitosis without any notable error, such as 
chromosomal missegregation, chromatin bridges, spindle defects, 
or alteration of early mitotic kinetics, as noted by monitoring hall-
mark chromatin changes during mitosis. Moreover, fixing a parallel 
set of LARG si cells just before or after filming, followed by staining 
for γ-H2AX (Yang, 2008), revealed no evidence of DNA damage 
(data not shown). That we could not detect any decoration of DNA 
with staining for γ-H2AX is further confirmation that depletion of 
LARG does not affect chromosome integrity or segregation 
dynamics.
Depletion of MyoGEF or ECT2 leads to contractile ring assembly 
and ingression phenotypes (Tatsumoto et al., 1999; Yüce et al., 
2005; Nishimura and Yonemura, 2006; Wu et al., 2006; Petronczki 
et al., 2007; Asiedu et al., 2009; Wolfe et al., 2009; Su et al., 2011b). 
localization data suggested that LARG may hold functional signifi-
cance in the midbody after complete furrow ingression during ab-
scission, a novel role both for LARG and for a RhoGEF.
To assess whether the localization of LARG correlated with some 
aspects of mitotic progression, we depleted HeLa cells of LARG us-
ing siRNA (LARG si; using siRNA #5 as described in Materials and 
Methods) and sought to identify any potential mitotic defects (Figure 
2A). Of interest, we noted a population of LARG si cells connected 
by intercellular bridges with distinct cell death morphologies (Figure 
2B). Cells were often found in tandem with drastic membrane disor-
ganization and pyknosis of the nuclei while attached by a membra-
nous extension that contained microtubule bundles, hallmark indi-
cations of active apoptosis (Kerr et al., 1972). To confirm that the 
morphological changes we observed in LARG si cells were due to 
apoptosis, we stained nonspecific siRNA–treated (NS) and LARG si 
cells with an antibody targeted against the cleaved form of cas-
pase-3. This staining revealed that LARG si cells displaying severe 
morphological changes were positive for cleaved caspase-3 and in-
deed undergoing apoptosis (Figure 2, B and C). In addition, in-
creased poly[ADP-ribose] polymerase (PARP) cleavage, another 
hallmark of apoptosis (Slee et al., 2001), was observed in immuno-
blots of cell lysates from LARG si cells (Figure 2, D and E). We further 
confirmed these data with additional siRNAs targeting LARG in both 
pool and individual forms (data not shown). Of importance, the 
FIGURE 2: Depletion of LARG results in apoptosis. (A) HeLa cells were treated with non- NS or LARG siRNA as 
described in Materials and Methods. Efficiency of endogenous LARG depletion (>90%) is shown by an immunoblot of 
cell lysates comparing the LARG signal in LARG siRNA lysates to decreasing equivalents of NS cell lysates. (B) HeLa cells 
were treated with LARG siRNA and fixed 12 h after release from double-thymidine G1/S synchronization to enrich for 
cells undergoing mitosis. Cells were stained for α-tubulin (red), cleaved caspase-3 (green), and DNA (blue). Images show 
examples of normal (top) and apoptotic (bottom) cytokinesis in LARG siRNA–treated cells. Bar, 10 μm. (C) Quantification 
of the percentage of cleaved caspase-3–positive cells (**p < 0.05, n = 1438 NS si cells, 1021 LARG si cells). (D) HeLa 
cells were transfected with the indicated siRNA together with expression plasmids for mCherry-LARG (Ch-LARG) or the 
siRNA-resistant Ch-LARG-5Res and analyzed by immunoblot for PARP-1 cleavage as described in Materials and 
Methods. The arrows indicate the position of endogenous LARG (endo) and exogenous mCherry-tagged LARG (exo). 
(E) Quantification of PARP-1 cleavage as fold change over control siRNA–treated cells normalized for HSP90 loading 
control (*p = 0.0008, **p < 0.02, n = 3 independent experiments).
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remained connected by the membranous 
intercellular bridge. The postingression mid-
body remained dense and seemingly well 
formed but underwent no further progres-
sion toward abscission. Of interest, we ob-
served that a subpopulation of LARG si cells 
stuck in this late cytokinesis further under-
went apoptosis (Figure 3, A and C). GFP-
H2B in this subpopulation formed aggre-
gates that were indicative of apoptosis 
(Figure 3C and Supplemental Video S3). Of 
LARG si cells going through mitosis, 44% of 
them died through apoptosis, a threefold 
increase over control NS si cells. Moreover, 
when specifically examining cells in late cy-
tokinesis, LARG si cells showed a fivefold 
increase in apoptosis compared with control 
NS si cells (Figure 3, C and D, and Supple-
mental Video S4). Of note, LARG si cells 
spend approximately twice as long in late 
cytokinesis as control cells, as described 
later (Figure 4). To account for these altered 
kinetics, we normalized mitotic apoptosis by 
time spent in preingression and postingres-
sion stages (Supplemental Figure S2). Over-
all, LARG si cells display a twofold increase 
in time-normalized, mitotic apoptosis. Pre-
cytokinesis also represents a twofold in-
crease in apoptosis, a stage in which there is 
no difference in time between LARG and NS 
si cells. On the other hand LARG si cells dis-
play a 2.5-fold increase in late cytokinetic 
apoptosis over NS si cells. Although LARG si 
cells show a trend toward increased time-
normalized apoptosis in cytokinesis as com-
pared to control cells, we have been unable 
to clearly show significance here. Thus it re-
mains to be completely resolved whether 
these two phenotypes—increased apopto-
sis and delayed abscission—that are ob-
served upon LARG depletion are distinct or 
causally linked.
Introduction of the pancaspase inhibitor 
Z-VAD-FMK prevented abscission-related 
apoptosis, and persistent intercellular 
bridges between daughter cells could often 
be visualized for the length of filming (Sup-
plemental Figure S3). That LARG si cells 
show full contractile ring ingression but have a significant popula-
tion that undergoes apoptosis during abscission is a unique pheno-
type among the mitotic RhoGEFs and suggests an essential role for 
LARG in abscission.
To determine at what stage in the late cytokinetic program LARG 
si cells become defective, we monitored HeLa cells stably express-
ing GFP-tubulin by live cell microscopy (Figure 4). Microtubules un-
dergo several distinct structural changes during the collapse of the 
cytokinetic furrow and resolution of the intercellular bridge through 
abscission (Fededa and Gerlich, 2012). Dense, overlapping microtu-
bules form at the spindle midzone during anaphase and become 
compressed in the cytokinetic furrow during contractile ring ingres-
sion. During late cytokinesis, just before abscission, microtubules 
undergo thinning in the intercellular bridge, overlap in the midbody, 
These range from an inability to properly assemble the contractile 
ring at the cell cortex to instability and perturbation of the ingres-
sion forces. The net result is the regression of the forming cytoki-
netic furrow to form a binucleate cell. GEF-H1 depletion results in a 
more variable phenotype but also ultimately yields incomplete fur-
row formation and polyploidy (Birkenfeld, 2007). Somewhat surpris-
ingly, unlike depletion of other mitotic RhoGEFs, LARG si cells can 
initiate contractile ring assembly and ingression without any notice-
able perturbations. This is followed by an unremarkable completion 
of furrow ingression to form a stable intercellular bridge and dense 
midbody structure just before abscission (Figure 3A and Supple-
mental Video S2).
A difference arose, however, in late cytokinesis. LARG si cells 
were unable to complete the final fission step. Thus daughter cells 
FIGURE 3: Depletion of LARG results in apoptosis in late cytokinesis. HeLa cells stably 
expressing GFP-H2B were treated with the indicated siRNA and synchronized at G1/S by the 
double-thymidine method. Cells were released from G1/S block and imaged by live cell 
microscopy with times indicated in minutes. (A) Bright-field images of cells progressing through 
mitosis after treatment with indicated siRNAs. Arrows highlight intercellular bridge in LARG 
si–treated cells. (B) Representative Western blot of the depletion of LARG in imaged cells. 
(C) GFP-H2B and bright-field images of LARG si–treated cells showing the classic degradation of 
DNA and membrane blebbing indicative of apoptosis after unresolved cytokinesis. Arrows 
highlight intercellular bridges. (D) Quantification of fates of NS and LARG si–treated cells that 
enter mitosis. Values expressed as a percentage of total number of cells entering mitosis during 
filming (**p < 0.0005, n = 262 NS si cells, 297 LARG si cells across three independent 
experiments).
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undergo subsequent rounds of mitosis. Similar multicellular intercel-
lular bridge accumulation has been seen in other studies of late cy-
tokinetic proteins and complexes, such as Sept9, exocyst complex, 
and rab35 GTPase (Gromley, 2005; Estey et al., 2010; Dambournet 
et al., 2011).
To achieve higher resolution of the microtubules comprising the 
intercellular bridge and detect potential structural abnormalities, we 
analyzed postmitotic fixed cells. Cells were either depleted of LARG 
or treated with nonspecific control siRNA, synchronized at G1/S by 
the double-thymidine method, released by washout, and allowed to 
proceed through mitosis. Cells were then fixed 10–12 h postrelease, 
when most cells should have completed abscission. Midbody-stage 
cells were scored as those with intercellular bridges comprising a 
thin microtubule network with a midbody that excluded α-tubulin 
antibody due to its dense matrix. LARG si cells displayed a twofold 
to threefold increase in persistent, midbody-stage intercellular 
bridges (Figure 4, C and D). We further noted that LARG si cells 
formed stable midbody bulges displaying hallmark α-tubulin anti-
body exclusion, as well as distal thinning of microtubules in the 
intercellular bridge (Mullins and Biesele, 1977; Steigemann and 
Gerlich, 2009; Figure 4C, inset).
and form sites of secondary ingression before being severed just 
before fission.
As with data obtained from tracking chromosomal dynamics 
(Figure 3), LARG si cells are able to proceed through early mitosis 
with comparable kinetics to control siRNA–transfected cells. We ob-
served a significant difference between LARG si and NS si cells upon 
completion of furrow ingression and narrowing of tubulin in the in-
tercellular bridge; LARG si cells display a twofold increase in the 
time to detect loss of GFP-tubulin signal from the intercellular 
bridge, (5.4 vs. 2.6 h in NS si cells), indicative of a defect in abscis-
sion or the molecular events immediately preceding abscission 
rather than earlier during contractile ring ingression (Figure 4, A and 
B). We noted that a population of LARG si cells never resolved tubu-
lin from the intercellular bridge before completion of filming (9 vs. 
2% in NS si cells) and others that went through apparent forced 
abscission events due to mechanical shearing of the intercellular 
bridge.
The inability of LARG si cells to complete abscission results in an 
accumulation of G1-like cells that remain connected by tubulin-
containing intercellular bridges (Supplemental Figure S4). This is 
evidence that in the absence of abscission, cells are still able to 
FIGURE 4: Cells depleted of LARG undergo normal mitotic kinetics but are unable to complete abscission. (A) HeLa 
cells stably expressing GFP–α-tubulin were treated with the indicated siRNA, synchronized at G1/S by the double-
thymidine method, and imaged by live cell microscopy beginning just before initiation of mitosis (times indicated in 
minutes). Arrow highlights presence of α-tubulin in LARG si cells well after control NS si cells have completed abscission. 
(B) Quantification of mitotic kinetics as measured by α-tubulin dynamics (*p < 0.0001, n = 97 NS si cells, n = 85 LARG si 
cells). Total, initiation of mitosis to intercellular α-tubulin resolution; condensation to ingression, initiation of mitosis to 
completion of contractile ring ingression; ingression to resolution, completion of contractile ring ingression to 
intercellular α-tubulin resolution. (C) HeLa cells were treated with siRNA, fixed 12 h after release from double thymidine, 
and stained for α-tubulin (green) and DNA (blue). Arrows highlight intercellular bridges that have completed contractile 
ring ingression. LARG si inset highlights Flemming body with proper midbody matrix (red arrow) and distal thinning of 
microtubules in the intercellular bridge (flanking white arrows). Bar, 10 μm. (D) Quantification of cells connected by 
persistent α-tubulin–containing intercellular bridges as fold over control NS si cells (**p < 0.0005, n ≥1500 cells for each 
siRNA across three independent experiments).
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et al., 2006). The LARG-W769A mutant showed a fivefold decrease 
in pull down with GST-Rho-G17A compared to wild-type (WT) trans-
fected LARG, whereas the LARG-E790A mutant surprisingly retained 
interaction with GST-Rho-G17A (Figure 6A). The LARG-Y940A mu-
tant, however, was completely unable to be pulled down by GST-
Rho-G17A (Figure 6A), identifying this mutant as a LARG that is in-
capable of activating RhoA. In our preliminary studies of LARG-Y940A, 
we noted that it was difficult to detect its expression. Of interest, 
we further noted a drastic decrease in viability in cells transiently 
These data suggest that LARG si cells form a proper midbody 
matrix and can assemble the primary abscission machinery but 
are unable to complete downstream fission events (Matuliene and 
Kuriyama, 2002; Elia et al., 2011). Moreover, apoptosis in LARG si 
cells (4–5 h post mitotic initiation) occurs after the time required for 
normal completion of cytokinesis and abscission in control NS si 
cells (3–4 h post mitotic initiation, as detected by resolution of GFP-
tubulin from the intercellular bridge). These observations are consis-
tent with the idea that depletion of LARG causes a defect in late 
cytokinesis just before abscission, in which a subpopulation of cells 
has an increased propensity for apoptosis (Figures 4B and 3, A and 
B). We further analyzed the localization of several well-characterized 
midbody-associated proteins, including ECT2, TSG101, Aurora-B, 
Plk1, RhoA, and Mklp1, and found them to all be properly localized 
in LARG si cells (Supplemental Figure S5). With the observed matu-
rity of LARG si intercellular bridges, it was not surprising to find that 
interrogated midbody and abscission machinery components were 
in well order. Together the data in Figure 4 are consistent with our 
hypothesis that LARG is necessary in the very late stages of cytoki-
nesis for the timely completion of abscission.
To begin to address a mechanism by which depletion of LARG 
causes a delay in late cytokinesis, we examined whether inhibition of 
Aurora-B could bypass the delay. Aurora-B kinase is important not 
only in early mitotic dynamics, but also in cytokinesis (Eggert et al., 
2006). Both Aurora-B and the budding yeast homologue lpl1 con-
trol an abscission checkpoint in the presence of chromosomal seg-
regation errors. Incomplete clearance of chromosomal material from 
the intercellular bridge results in sustained Aurora-B activity and sta-
bilization of the bridge, preventing abscission (Norden et al., 2006; 
Steigemann et al., 2009). Moreover, inhibition of Aurora-B activity is 
sufficient to relieve the abscission checkpoint in the presence of 
nuclear pore formation perturbations (Mackay et al., 2010). Here 
asynchronous siRNA-transfected cells were treated with 2 μM 
ZM447439, a small-molecule inhibitor of Aurora-B, or dimethyl sul-
foxide (DMSO) vehicle for 2 h before fixation. With vehicle treat-
ment, LARG si cells displayed typical increase in persistent intercel-
lular bridges compared to NS si cells (Figure 5, A–C). On inhibition 
of Aurora-B, however, in both LARG and NS cells we observed a 
significant decrease in the number of midbody stage cells (Figure 
5B). Of importance, LARG si displayed a significant decrease in the 
number of midbody stage cells even when normalized for the de-
crease observed with NS si cells (Figure 5C), suggesting that Aurora-
B activity mediates delayed abscission kinetics in the absence of 
LARG. We noted no distinguishable increase in binucleate cell for-
mation between NS and LARG si cells, indicating that the resolution 
of intercellular bridges in LARG si cells when treated with ZM447439 
was not due to regression of the cytokinetic furrow. In addition, im-
munofluorescence with an Aurora-B antibody and phospho-specific 
Aurora-B antibody to detect active Aurora-B showed midbody local-
ization in NS si and LARG si cells (Supplemental Figure S5), consis-
tent with a role for Aurora-B in mediating delayed abscission upon 
LARG depletion.
Finally, by generating a mutant LARG deficient in RhoA activa-
tion, we attempted to examine whether the role of LARG in delayed 
abscission and apoptosis requires its canonical activation of RhoA. 
To generate such a mutant, we tested several different single–amino 
acid substitutions, based on previous biochemical and structural 
data (Figure 6C; Kristelly et al., 2003; Aittaleb et al., 2009) and as-
sayed for loss of interaction with RhoA-G17A, a nucleotide-empty 
form of RhoA. The ability of glutathione S-transferase (GST)–Rho-
G17A to pull down LARG from cell lysates is a convenient assay for 
detecting LARG that is active in terms of RhoGEF activity (Garcia-Mata 
FIGURE 5: Cells depleted of LARG undergo an Aurora-B–dependent 
delay in abscission kinetics. (A) Asynchronous HeLa cells were treated 
with siRNA for 72 h. Cells were treated with either DMSO vehicle or 
2 μM ZM447439 to inhibit Aurora-B for 2 h before fixing and staining 
for α-tubulin (green) and DNA (blue). Arrows highlight midbody-stage 
intercellular bridges. Bar, 10 μm. (B) Quantification of the percentage 
of midbody-stage intercellular bridges for both NS si and LARG si 
cells in the presence of vehicle or Aurora-B inhibitor (*p ≤ 0.0012, 
DMSO vs. ZM447439; DMSO, NS si = 7478 cells, LARG si = 3388 cells; 
ZM447439, NS si = 7229 cells, LARG si = 4249 cells; across four 
independent experiments). (C) Percentage of midbody-stage 
intercellular bridges for LARG si cells normalized by subtraction 
of NS si cell percentages for each DMSO and ZM447439 treatment 
(*p = 0.0045).
Volume 24 September 15, 2013 LARG is required for abscission | 2791 
Wu et al., 2006; Birkenfeld, 2007; Su et al., 
2011b). Depletion of LARG arrests the ab-
scission process, resulting in cells that have 
completed contractile ring ingression but 
remain unable to complete abscission with 
proper kinetics, a temporally distinct re-
quirement from previously identified mitotic 
RhoGEFs (Figure 6D). The presence of Flem-
ming bodies with proper midbody matrix 
formation in LARG si cells suggests that cells 
are able to complete ingression and begin 
the proper localization of endosomal-de-
rived components and abscission machinery 
but are unable to proceed forward to sever 
microtubules and begin the final fission 
event (Elia et al., 2011; Neto and Gould, 
2011). Moreover, we noted a subpopulation 
of LARG si cells with an increased propen-
sity for apoptosis while arrested in late 
cytokinesis.
Work on an Aurora-B–controlled check-
point in abscission (Mackay et al., 2010; 
Steigemann, 2009) suggests that the cellu-
lar sampling algorithm used to monitor ab-
scission and drive the final outcome of mi-
totic division is not merely mechanical in 
nature but involves multiplexed signaling 
cascades. Our result showing that treatment 
of LARG si cells with an Aurora-B inhibitor 
allows cells to bypass the delay in abscission 
suggests that Aurora-B plays an active role 
in the observed delayed kinetics. Not only is 
this exciting in that it uncovers a likely mech-
anistic pathway responsible for delayed ab-
scission kinetics when LARG is depleted 
from cells, it also reveals a novel insight into 
cytokinetic regulation. The Aurora-B abscis-
sion checkpoint pathway has been believed 
to be chromatin dependent and target the 
clearance of genetic material from the intercellular bridge, although 
additional work suggests that this checkpoint is also activated when 
nuclear pores are not reformed properly (Mackay et al., 2010). We 
showed that depletion of LARG does not disrupt normal chromo-
somal segregation fidelity. Yet, when LARG is absent, cells are un-
able to satisfy the Aurora-B–mediated abscission checkpoint. Thus 
our results propose a nuclear- and chromatin-independent mecha-
nism of sustained checkpoint activity. These data suggest a more 
omnipotent abscission checkpoint, one that ensures not only proper 
completion of cytokinesis in monitoring chromosomal clearance, 
but also a multitude of convergent mechanical and biochemical sig-
naling pathways.
LARG is not the first regulator of cytokinesis or abscission whose 
disruption results in apoptosis; however, LARG and GEF-H1 appear 
to be exclusive as RhoGEFs whose cytokinetic impairment can result 
in cell death (Tomas, 2004; Birkenfeld, 2007; Pohl and Jentsch, 
2008; Estey et al., 2010). Outcomes in which daughter cells are not 
properly separated result in a state of cellular aneuploidy, genetic 
instability beneficial for tumor formation and growth, as well as in-
creased susceptibility to transformation after carcinogenic exposure 
(Fujiwara, 2005). A common therapeutic approach for targeting 
mitotic cells is to use antispindle agents, such as vinca alkaloids and 
taxanes. However, populations of cells can undergo slippage out of 
overexpressing this mutant compared to WT LARG. This led us to 
hypothesize that LARG-Y940A, which cannot bind to RhoA, causes 
apoptosis in a dominant-negative manner. Indeed, we observed in-
creased PARP cleavage with overexpression of LARG-Y940A (Figure 
6B). Surprisingly, we also observed increased apoptosis in cells ex-
pressing LARG-E790A and, to a lesser degree, LARG-W769A. These 
observations of increased apoptosis upon expression of RhoGEF 
activity–deficient LARG suggest that LARG-Y940A, and possibly the 
other mutants, are functioning in a dominant-negative manner and 
thus are consistent with our results here using siRNA depletion of 
LARG. Further, these data suggest that RhoA activation is required 
for LARG’s role in maintaining cell viability and, by extension, LARG’s 
role in late cytokinesis. We were unable to directly test this; the fact 
that LARG-Y940A promotes apoptosis prevented us from using it in 
siRNA rescue experiments and makes it technically challenging to 
identify late-cytokinesis cells expressing this mutant of LARG.
DISCUSSION
The studies presented here show a novel and specific role for LARG 
in cytokinesis. Depletion of previously identified mitotic RhoGEFs 
results in cytokinetic defects ranging from the inability to properly 
initiate contractile ring ingression to cortical instability and failure to 
fully ingress and form the cytokinetic furrow (Tatsumoto et al., 1999; 
FIGURE 6: Y940 of the DH core of LARG is critical for binding to RhoA, and mutation leads to 
apoptosis. (A) HeLa cells were transfected with indicated plasmid. At 48 h posttransfection, cell 
lysates were harvested and subject to GST-G17A-RhoA pull down. Relative binding to RhoA was 
determined by immunoblot for LARG and pull down and input fractions compared for each 
respective LARG plasmid. I, 5% total input; P, 50% total pull down. Top bands, exogenous 
mCherry-tagged LARG proteins; bottom bands, endogenous LARG. (B) HeLa cells were 
transfected with indicated plasmid for 48 h, cell lysates harvested, and relative apoptosis 
determined by immunoblot for PARP cleavage. (C) Crystal structure of DH/PH domain of LARG 
in complex with RhoA from PDB database (1X86; Kristelly et al., 2003) depicting residues (pink) 
of the DH domain (gray) targeted here in mutation studies and relative locations to RhoA 
(brown). (D) Multiple RhoGEFs exhibit temporally distinct functions for the proper completion of 
mitosis. See the text for discussion.
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requirement for LARG in late cytokinesis should provide crucial 
insight into the upstream modalities of abscission regulation.
MATERIALS AND METHODS
Cell culture, plasmids, and transfections
Cell lines were cultured in either DMEM (HeLa) or 50:50 DMEM:F12 
(RPE1) with 10% fetal bovine serum at 37°C and 5% CO2. mCherry-
LARG (Ch-LARG) was constructed as previously described (Grabocka 
and Wedegaertner, 2007). Cells were transfected in six-well plates 
with HiPerFect (Qiagen, Valencia, CA) for siRNA or Lipofectamine 
2000 (Invitrogen, Carlsbad, CA) for siRNA and plasmid cotransfec-
tion. For siRNA depletion experiments, cells were transfected with 
either NS control siRNA (D-001810-01) or those targeted against 
LARG, ARHGEF12 siGenome ON-TARGET plus set (J-008480; 
Dharmacon, Lafayette, CO), at 50 nM concentration using the man-
ufacturer’s instructions. LARG siRNA #5 was used for further single-
siRNA studies (J-008480-05, GAUCAAAUCUCGUCAGAAA). Cells 
were then harvested 48–72 h later unless otherwise noted. siRNA 
resistance (Ch-LARG-5res) was generated by introduction of silent 
mutations into the LARG siRNA #5 binding sequence of Ch-LARG 
by QuikChange mutagenesis (GATCAAAAGTCGTCAGAAA). DH-
domain mutants were constructed by QuikChange PCR mutagen-
esis of W769 (mCh-LARG-W769A), E790 (mCh-LARG-E790A), or 
Y940 (mCh-LARG-Y940A) to alanine in mCherry-LARG (Ch-LARG).
Immunoblotting
Cells were lysed and subjected to standard immunoblotting proce-
dures using overnight incubation of primary antibodies with 1 h of 
secondary antibody incubation. Primary antibody dilutions were 
anti-LARG, 1:2000 (goat RD AF4737, R&D Systems, Minneapolis, 
MN; rabbit A301-959A, Bethyl Laboratories, Montgomery, TX; rab-
bit H70, Santa Cruz Biotechnology, Santa Cruz Biotechnology, CA); 
rabbit anti-PARP1, 1:2000 (Santa Cruz Biotechnology); mouse anti–
α-tubulin, 1:2000 (DM1A; Sigma-Aldrich, St. Louis, MO); and rabbit 
anti-HSP90 α/β, 1:25,000 (Santa Cruz Biotechnology). Secondary 
antibody coupled to horseradish peroxidase was used at 1:10,000 
(Promega, Madison, WI). Densitometry of Western blots was per-
formed using Quantity-One (Bio-Rad, Hercules, CA).
Immunofluorescence
Cells were washed with phosphate-buffered saline and fixed in ei-
ther 10% trichloroacetic acid at 4°C for 10 min or 3.7% paraformal-
dehyde at 24°C for 15 min. Cells were then permeabilized by block-
ing in 1% Triton X-100 in Tris-buffered saline containing 2.5% nonfat 
milk or bovine serum albumin. Primary antibodies were incubated 
for 1.5 h and secondary antibodies for 0.5 h. Primary antibody dilu-
tions were anti-LARG, 1:1000 (goat RD AF4737, R&D Systems; rab-
bit A301-959A, Bethyl Laboratories; rabbit H70, Santa Cruz Biotech-
nology); rabbit anti–cleaved caspase-3, 1:1000 (Cell Signaling 
Technology, Beverly, MA); mouse anti-RhoA, 1:500 (sc-179, Santa 
Cruz Biotechnology); rabbit anti-MKLP-1 (N-19, Santa Cruz Biotech-
nology), mouse anti-TSG101 (ab83; Abcam, Cambridge, MA), rab-
bit anti-ECT2 (sc-25637; Santa Cruz Biotechnology), mouse anti-
PLK1 (05-844, clone 35-206; Millipore, Temecula, CA), Mklp1 
(sc-867, Santa Cruz Biotechnology), rabbit anti–Aurora-B pT232 
(Rockland, Gilbertsville, PA), rabbit Aurora-B (ab70238; Abcam), and 
mouse anti–α-tubulin, 1:2000 (DM1A; Sigma-Aldrich). Alexa Fluor 
594– and 488–conjugated secondary antibodies (Molecular Probes, 
Eugene, OR) were used for primary antibody detection at 1:100. 
4′,6-Diamidino-2-phenylindole was used for nucleus staining at 
0.1 μg/ml (Molecular Probes). Coverslips were mounted using 
Prolong Antifade reagent (Molecular Probes) and imaged using 
this block, continuing mitotic division and thus proliferating with po-
tentially increased genetic instability (Rieder and Palazzo, 1992; 
Di Leonardo et al., 1997; Tao et al., 2005). Therefore proteins that 
regulate processes downstream of spindle assembly, such as mitotic 
exit, provide alternative anticancer targets (Huang et al., 2009). 
LARG and other proteins whose disruption likewise results in apop-
tosis during failed abscission rather than furrow regression and ane-
uploidy pose therapeutically enticing targets. One important ques-
tion that remains to be answered is exactly how and when apoptosis 
is being triggered. Further, it is not understood whether the cytoki-
netic defect and resultant delay may be causing apoptosis and, if so, 
the mechanistic derivation of this signal. Finally, although siRNA-
resistant LARG could rescue the increased apoptosis caused by 
LARG depletion, we could not consistently observe overexpressed 
LARG at the midbody. Thus it remains unresolved whether midbody 
localization of LARG is essential for its antiapoptotic function.
RhoGEFs identified as necessary for mitosis have proven to be 
critical for the proper assembly, constriction, and stability of the con-
tractile ring. There appear to be, however, no previously shown 
postingression phenotypes during late cytokinesis and subsequent 
abscission when these RhoGEFs are siRNA depleted. This posed 
the intriguing question as to whether regulation of RhoA activity is a 
crucial step in late cytokinesis and, correlatively, if there is a function-
ally relevant RhoGEF after complete contractile ring ingression nec-
essary for the completion of abscission. Recent work revealed a role 
for citron kinase (CIT-K) upstream of RhoA at the midbody stage of 
cytokinesis (Gai et al., 2011). Overexpression of CIT-K results in in-
crease in active RhoA in late cytokinesis, leading to abscission delay 
that can be rescued by inactivation of RhoA by C3-toxin. Conversely, 
depletion of CIT-K results in significant reduction of active RhoA in 
late cytokinesis and, of interest, reduction in the total RhoGEF activ-
ity at this stage. It was noted, however, that no disruption in localiza-
tion or activity of the canonical mitotic RhoGEFs ECT2 and GEF-H1 
or RhoGAPs p190RhoGAP and RACGAP1 could be observed with 
CIT-K depletion. Therefore it is likely that the CIT-K and RhoA path-
way in late cytokinesis is connected to a yet-unfound mitotic Rho-
GEF. Given that depletion of LARG from cells results in an abscission 
delay and sustained Aurora-B checkpoint activity, it is a rather fitting 
candidate for such a role. It will therefore be exciting to determine 
the late cytokinetic interactome of LARG and whether it is indeed 
cooperating with CIT-K to control the activity and stable localization 
of RhoA just before abscission.
Mutational analysis of LARG DH–domain residues showed that 
Y940 is critical for binding to RhoA and, further, that LARG-Y940A 
appears to act in a dominant-negative manner, ultimately causing 
apoptosis. Cells depleted of LARG have a high propensity for ab-
scission-related apoptosis while attempting to undergo cytokinesis. 
Given that overexpression of LARG-Y940A, which is completely un-
able to bind RhoA, also results in apoptosis, we hypothesize that 
these are related phenotypes and that LARG binding to RhoA is 
important for cell viability. We anticipate that this regulation of RhoA 
activity is critical for proper late cytokinesis and abscission kinetics 
and, ultimately, viability in cytokinesis. Further experimentation is 
needed, however, to confirm that these are interconnected phe-
nomena. Further studies should elucidate with finer detail the tem-
poral requirement for LARG in abscission and whether there is a 
functional requirement for discrete RhoA activation during certain 
events in the abscission process after completion of contractile ring 
ingression.
In summary, this study shows that depletion of LARG causes a de-
lay in late cytokinesis and thus provides evidence for an unexpected 
mitotic role for LARG. Further understanding of the molecular 
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an Olympus BX-61 microscope with an ORCA-ER CCD camera 
(Hamamatsu, Bridgewater, NJ) and UPlanFl 40× or PlanApo 60× ob-
jective (Olympus) controlled by SlideBook (Intelligent Imaging 
Innovations, Denver, CO). ImageJ (National Institutes of Health, 
Bethesda, MD) and GIMP (www.gimp.org/) were used for image 
processing. Determination of midbody-stage cells was done by 
analysis of α-tubulin staining. Aurora-B inhibition was achieved by 
addition of 2 μM ZM447439 (Biomol, Plymouth, PA) 2 h before fixa-
tion as indicated.
Live cell imaging
HeLa cells stably expressing GFP-tagged histone H2B (GFP-H2B) or 
GFP-tagged tubulin (GFP-tubulin) were seeded on six-well plates, 
transfected with either control or LARG targeted siRNA at 10% con-
fluency, and synchronized at G1/S by the double-thymidine method. 
After washout, cells were released for 3–4 h before being placed in 
a temperature-controlled chamber for filming. Bright-field and GFP 
images were acquired every 5 min for 24–36 h using a Nikon TE2000 
microscope (Nikon, Tokyo, Japan) controlled by MetaMorph 
(Molecular Devices, Sunnyvale, CA). For caspase inhibition experi-
ments, cells were treated with vehicle (DMSO) or 25 μM Z-VAD-FMK 
(Santa Cruz Biotechnology) immediately after washout from G1/S 
block. ImageJ and GIMP were used for image stack analysis and 
montage composition.
RhoA binding assays
LARG plasmids were transfected in HeLa cells as previously described. 
After 24 or 48 h of expression, cell lysates were harvested and sub-
jected to GST-G17A-RhoA binding experiments, as described 
(Garcia-Mata et al., 2006). Relative levels of binding to transition-state 
mimic RhoA were determined by comparison of LARG detected by 
immunoblot in pull-down fractions to input as indicated.
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